Assessing the Influence of Subsequent Immunotherapy on Overall Survival in Patients with Unresectable Stage III Non-Small Cell Lung Cancer from the PACIFIC Study
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL（2021）
Key words
Durvalumab,Modified 2-stage method,Overall survival,PACIFIC,Rank Preserving Structural Failure Time,Model
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined